Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | TBC1D10A (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TBC1D10A mRNA | CTD | PMID:22079256 | 1,1-dichloroethene | decreases expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of TBC1D10A mRNA | CTD | PMID:26682919 | 1,2-dimethylhydrazine | increases expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of TBC1D10A mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Tbc1d10a (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of TBC1D10A mRNA] | CTD | PMID:22206623 | 17alpha-ethynylestradiol | multiple interactions | ISO | Tbc1d10a (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TBC1D10A mRNA | CTD | PMID:17942748 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | TBC1D10A (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Tbc1d10a (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TBC1D10A mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TBC1D10A mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TBC1D10A mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TBC1D10A mRNA | CTD | PMID:21215274 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of TBC1D10A mRNA | CTD | PMID:20188158 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Tbc1d10a (Mus musculus) | 6480464 | bisphenol S affects the methylation of TBC1D10A gene | CTD | PMID:31683443 | acrylamide | increases expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | Acrylamide results in increased expression of TBC1D10A mRNA | CTD | PMID:30807115 | aflatoxin B1 | decreases methylation | ISO | TBC1D10A (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of TBC1D10A gene and Aflatoxin B1 results in decreased methylation of TBC1D10A intron | CTD | PMID:27153756 and PMID:30157460 | aristolochic acid A | increases expression | ISO | TBC1D10A (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of TBC1D10A mRNA | CTD | PMID:33212167 | arsenous acid | increases expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of TBC1D10A mRNA | CTD | PMID:35676786 | benzo[a]pyrene | decreases methylation | ISO | TBC1D10A (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of TBC1D10A promoter | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | increases expression | ISO | TBC1D10A (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of TBC1D10A mRNA | CTD | PMID:31163220 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of TBC1D10A mRNA | CTD | PMID:30816183 and PMID:32528016 | bisphenol A | decreases methylation | ISO | TBC1D10A (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of TBC1D10A gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | TBC1D10A (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of TBC1D10A protein | CTD | PMID:31675489 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of TBC1D10A mRNA | CTD | PMID:33296240 | butanal | increases expression | ISO | TBC1D10A (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of TBC1D10A mRNA | CTD | PMID:26079696 | carbon nanotube | decreases expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of TBC1D10A mRNA | CTD | PMID:25620056 | chlorpyrifos | increases expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of TBC1D10A mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | Tbc1d10a (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TBC1D10A gene | CTD | PMID:20938992 | cisplatin | multiple interactions | ISO | TBC1D10A (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of TBC1D10A mRNA | CTD | PMID:27392435 | copper(II) sulfate | increases expression | ISO | TBC1D10A (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of TBC1D10A mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | ISO | TBC1D10A (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of TBC1D10A mRNA | CTD | PMID:25562108 | decabromodiphenyl ether | decreases expression | ISO | TBC1D10A (Homo sapiens) | 6480464 | decabromobiphenyl ether results in decreased expression of TBC1D10A protein | CTD | PMID:31675489 | diarsenic trioxide | increases expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of TBC1D10A mRNA | CTD | PMID:35676786 | doxorubicin | decreases expression | ISO | TBC1D10A (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of TBC1D10A mRNA | CTD | PMID:29803840 | folic acid | multiple interactions | ISO | Tbc1d10a (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TBC1D10A gene more ... | CTD | PMID:20938992 and PMID:22206623 | FR900359 | affects phosphorylation | ISO | TBC1D10A (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of TBC1D10A protein | CTD | PMID:37730182 | L-methionine | multiple interactions | ISO | Tbc1d10a (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TBC1D10A gene | CTD | PMID:20938992 | lipopolysaccharide | increases expression | ISO | TBC1D10A (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of TBC1D10A mRNA | CTD | PMID:35811015 | lipopolysaccharide | multiple interactions | ISO | TBC1D10A (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TBC1D10A mRNA | CTD | PMID:35811015 | niclosamide | increases expression | ISO | TBC1D10A (Homo sapiens) | 6480464 | Niclosamide results in increased expression of TBC1D10A mRNA | CTD | PMID:36318118 | p-chloromercuribenzoic acid | decreases expression | ISO | TBC1D10A (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of TBC1D10A mRNA | CTD | PMID:27188386 | paracetamol | decreases expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of TBC1D10A mRNA | CTD | PMID:17585979 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of TBC1D10A mRNA | CTD | PMID:33387578 | paracetamol | affects expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | Acetaminophen affects the expression of TBC1D10A mRNA | CTD | PMID:17562736 | PCB138 | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 | perfluorohexanesulfonic acid | decreases expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of TBC1D10A mRNA | CTD | PMID:37995155 | phenobarbital | affects expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | Phenobarbital affects the expression of TBC1D10A mRNA | CTD | PMID:19136022 | pirinixic acid | affects expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | pirinixic acid affects the expression of TBC1D10A mRNA | CTD | PMID:19136022 | potassium chromate | decreases expression | ISO | TBC1D10A (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of TBC1D10A mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | TBC1D10A (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TBC1D10A mRNA | CTD | PMID:22079256 | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of TBC1D10A mRNA | CTD | PMID:28903501 | resveratrol | multiple interactions | ISO | TBC1D10A (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of TBC1D10A mRNA | CTD | PMID:23557933 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | TBC1D10A (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TBC1D10A mRNA | CTD | PMID:35811015 | urethane | increases expression | ISO | TBC1D10A (Homo sapiens) | 6480464 | Urethane results in increased expression of TBC1D10A mRNA | CTD | PMID:28818685 | valproic acid | increases methylation | ISO | TBC1D10A (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of TBC1D10A gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | Tbc1d10a (Mus musculus) | 6480464 | Valproic Acid affects the expression of TBC1D10A mRNA | CTD | PMID:17963808 | |